Published in J Biol Chem on May 07, 2001
Inflammation, stress, and diabetes. J Clin Invest (2005) 17.11
Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms. Mol Cell Biol (2004) 3.79
SOCS regulation of the JAK/STAT signalling pathway. Semin Cell Dev Biol (2008) 2.72
Coordinated regulation of nutrient and inflammatory responses by STAMP2 is essential for metabolic homeostasis. Cell (2007) 2.35
Experimental endotoxemia induces adipose inflammation and insulin resistance in humans. Diabetes (2009) 2.27
Suppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and function. Trends Immunol (2009) 1.89
Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice. J Clin Invest (2004) 1.82
Molecular signatures of obstructive sleep apnea in adults: a review and perspective. Sleep (2009) 1.76
The role of adipose tissue and adipokines in obesity-related inflammatory diseases. Mediators Inflamm (2010) 1.59
cJun NH2-terminal kinase 1 (JNK1): roles in metabolic regulation of insulin resistance. Trends Biochem Sci (2010) 1.36
Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention. Diabetes Metab Syndr Obes (2010) 1.28
SOCS-6 binds to insulin receptor substrate 4, and mice lacking the SOCS-6 gene exhibit mild growth retardation. Mol Cell Biol (2002) 1.28
Activation of SOCS-3 by resistin. Mol Cell Biol (2005) 1.27
SOCS proteins in development and disease. Am J Clin Exp Immunol (2013) 1.17
Deletion of SOCS7 leads to enhanced insulin action and enlarged islets of Langerhans. J Clin Invest (2005) 1.14
Exercise therapy in type 2 diabetes. Acta Diabetol (2009) 1.12
Development of hydrocephalus in mice lacking SOCS7. Proc Natl Acad Sci U S A (2004) 1.07
Expression and suppressive effects of interleukin-19 on vascular smooth muscle cell pathophysiology and development of intimal hyperplasia. Am J Pathol (2008) 1.05
Roles of IL-6-gp130 Signaling in Vascular Inflammation. Curr Cardiol Rev (2008) 1.04
Two Drosophila suppressors of cytokine signaling (SOCS) differentially regulate JAK and EGFR pathway activities. BMC Cell Biol (2004) 1.01
Temporal profiling of the transcriptional basis for the development of corticosteroid-induced insulin resistance in rat muscle. J Endocrinol (2005) 1.00
Suppressor of cytokine signaling 6 (SOCS6) negatively regulates Flt3 signal transduction through direct binding to phosphorylated tyrosines 591 and 919 of Flt3. J Biol Chem (2012) 0.94
Activation of peroxisome proliferator-activated receptor-β/-δ (PPAR-β/-δ) ameliorates insulin signaling and reduces SOCS3 levels by inhibiting STAT3 in interleukin-6-stimulated adipocytes. Diabetes (2011) 0.92
Satellite cells derived from obese humans with type 2 diabetes and differentiated into myocytes in vitro exhibit abnormal response to IL-6. PLoS One (2012) 0.92
HIV-protease inhibitors induce expression of suppressor of cytokine signaling-1 in insulin-sensitive tissues and promote insulin resistance and type 2 diabetes mellitus. Am J Physiol Endocrinol Metab (2008) 0.91
Ketoacidosis at diagnosis of type 1 diabetes in children and adolescents: frequency and clinical characteristics. J Diabetes Metab Disord (2013) 0.91
SOCS-6 negatively regulates T cell activation through targeting p56lck to proteasomal degradation. J Biol Chem (2009) 0.90
Knock your SOCS off! J Clin Invest (2005) 0.89
Mathematical modeling of corticosteroid pharmacogenomics in rat muscle following acute and chronic methylprednisolone dosing. Mol Pharm (2008) 0.87
Insulin and GH signaling in human skeletal muscle in vivo following exogenous GH exposure: impact of an oral glucose load. PLoS One (2011) 0.87
SOCS1 Mimetics and Antagonists: A Complementary Approach to Positive and Negative Regulation of Immune Function. Front Immunol (2015) 0.84
Suppressor of cytokine signalling-6 promotes neurite outgrowth via JAK2/STAT5-mediated signalling pathway, involving negative feedback inhibition. PLoS One (2011) 0.83
Molecular mechanisms of insulin resistance in chronic kidney disease. Kidney Int (2015) 0.82
SOCS-1 deficiency does not prevent diet-induced insulin resistance. Biochem Biophys Res Commun (2008) 0.82
Effects of GH in human muscle and fat. Pediatr Nephrol (2009) 0.82
MiR-19a regulates PTEN expression to mediate glycogen synthesis in hepatocytes. Sci Rep (2015) 0.81
The role of suppressors of cytokine signalling in human neoplasms. Mol Biol Int (2014) 0.81
Inputs and outputs of insulin receptor. Protein Cell (2014) 0.78
Increases in insulin sensitivity among obese youth are associated with gene expression changes in whole blood. Obesity (Silver Spring) (2014) 0.78
Pim3 negatively regulates glucose-stimulated insulin secretion. Islets (2010) 0.77
Psychoneuroimmune implications of type 2 diabetes: redux. Immunol Allergy Clin North Am (2009) 0.76
FOXO1 content is reduced in cystic fibrosis and increases with IGF-I treatment. Int J Mol Sci (2014) 0.75
Functional homology of mammalian and yeast RAS genes. Cell (1985) 14.01
In yeast, RAS proteins are controlling elements of adenylate cyclase. Cell (1985) 11.63
Three different genes in S. cerevisiae encode the catalytic subunits of the cAMP-dependent protein kinase. Cell (1987) 6.35
Cloning and characterization of BCY1, a locus encoding a regulatory subunit of the cyclic AMP-dependent protein kinase in Saccharomyces cerevisiae. Mol Cell Biol (1987) 5.03
Effect of using protocols on medical care: randomised trial of three methods of taking an antenatal history. BMJ (1992) 4.07
Outbreak of HIV infection in a Scottish prison. BMJ (1995) 3.82
Eligibility for CPR: is every death a cardiac arrest? CMAJ (1989) 3.26
Phagocytosis promotes programmed cell death in C. elegans. Nature (2001) 3.12
Rigorous feedback control of cAMP levels in Saccharomyces cerevisiae. Genes Dev (1987) 2.58
SCH9, a gene of Saccharomyces cerevisiae that encodes a protein distinct from, but functionally and structurally related to, cAMP-dependent protein kinase catalytic subunits. Genes Dev (1988) 2.57
Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay. J Clin Invest (1977) 2.46
Are preferences over health states complete? Health Econ (2000) 2.40
Randomized controlled trial of brief cognitive behaviour therapy versus treatment as usual in recurrent deliberate self-harm: the POPMACT study. Psychol Med (2003) 2.16
Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990-1996: are current harm reduction strategies working? J Infect (2000) 1.94
BRG-1 is recruited to estrogen-responsive promoters and cooperates with factors involved in histone acetylation. Mol Cell Biol (2000) 1.80
Murray River water, raised cyanobacterial cell counts, and gastrointestinal and dermatological symptoms. Med J Aust (1995) 1.62
Anonymous HIV surveillance with risk factor elicitation at Scotland's largest prison, Barlinnie. AIDS (1995) 1.61
Vaccine prophylaxis of abattoir-associated Q fever. Lancet (1984) 1.55
Molecular investigation into outbreak of HIV in a Scottish prison. BMJ (1997) 1.49
The incidence and prevalence of HIV infection among childbearing women living in Edinburgh city, 1982-1995. AIDS (1998) 1.48
Studies of RAS function in the yeast Saccharomyces cerevisiae. Cold Spring Harb Symp Quant Biol (1988) 1.48
Homozygous nonsense mutation in the insulin receptor gene of a patient with severe congenital insulin resistance: leprechaunism and the role of the insulin-like growth factor receptor. Clin Endocrinol (Oxf) (1996) 1.42
Somatomedin-C receptors and growth effects in human breast cells maintained in long-term tissue culture. Cancer Res (1984) 1.40
Regulation of heme oxygenase-1 expression in vivo and in vitro in hyperoxic lung injury. Am J Respir Cell Mol Biol (1996) 1.36
Incidence of hepatitis C virus infection and associated risk factors among Scottish prison inmates: a cohort study. Am J Epidemiol (2004) 1.36
Phenotypic features and proliferative activity of B cell progenitors in X-linked agammaglobulinemia. J Immunol (1990) 1.35
AIB1 enhances estrogen-dependent induction of cyclin D1 expression. Cancer Res (2001) 1.35
Hepatitis C virus antibody prevalence among injecting drug users in Glasgow has fallen but remains high. Commun Dis Public Health (1998) 1.35
Insulin-like growth factor I/somatomedin C: a potent inducer of oligodendrocyte development. Proc Natl Acad Sci U S A (1986) 1.27
A South Australian Salmonella Mbandaka outbreak investigation using a database to select controls. Aust N Z J Public Health (1998) 1.25
Outreach STD clinics for prostitutes in Edinburgh. Int J STD AIDS (1995) 1.25
Expression in Escherichia coli of BCY1, the regulatory subunit of cyclic AMP-dependent protein kinase from Saccharomyces cerevisiae. Purification and characterization. J Biol Chem (1987) 1.24
Health effects of exposure to cyanobacteria (blue-green algae) during recreational water-related activities. Aust N Z J Public Health (1997) 1.24
Toward a national curriculum in informatics. Can Fam Physician (1998) 1.19
Interaction of human suppressor of cytokine signaling (SOCS)-2 with the insulin-like growth factor-I receptor. J Biol Chem (1998) 1.19
Extraordinary number of gene rearrangements in the mitochondrial genomes of lice (Phthiraptera: Insecta). Insect Mol Biol (2006) 1.18
The type II insulin-like growth factor receptor does not mediate deoxyribonucleic acid synthesis in human fibroblasts. J Clin Endocrinol Metab (1987) 1.17
Caloric restriction and 7,12-dimethylbenz(a)anthracene-induced mammary tumor growth in rats: alterations in circulating insulin, insulin-like growth factors I and II, and epidermal growth factor. Cancer Res (1989) 1.15
A mutation in the catalytic subunit of cAMP-dependent protein kinase that disrupts regulation. Science (1988) 1.15
Incidence and distribution of experimental metastases in mutant mice with defective organ microenvironments (genotypes Sl/Sld and W/Wv). Cancer Res (1992) 1.14
Prevalence of chronic viral hepatitis in people of south Asian ethnicity living in England: the prevalence cannot necessarily be predicted from the prevalence in the country of origin. J Viral Hepat (2009) 1.14
The somatomedin C binding protein: evidence for a heterologous subunit structure. J Clin Endocrinol Metab (1980) 1.13
Preclinical evaluation of dual PI3K-mTOR inhibitors and histone deacetylase inhibitors in head and neck squamous cell carcinoma. Br J Cancer (2011) 1.13
Metastatic but not primary melanoma cell lines grow in vitro independently of exogenous growth factors. Int J Cancer (1987) 1.11
Methylated DNA-binding protein is present in various mammalian cell types. Nucleic Acids Res (1988) 1.10
Human sentinels for arbovirus surveillance and regional risk classification in South Australia. Med J Aust (1994) 1.09
Insulin-like growth factor-I binds selectively to human peripheral blood monocytes and B-lymphocytes. J Clin Endocrinol Metab (1991) 1.07
Outcomes in rural obstetrics, Atherton Hospital 1991-2000. Aust J Rural Health (2001) 1.06
Differential regulation of collagen types I and III expression in cardiac fibroblasts by AGEs through TRB3/MAPK signaling pathway. Cell Mol Life Sci (2008) 1.05
Neuropathy in multiple symmetric lipomatosis. Madelung's disease. Brain (1988) 1.05
Rates of subsequent surgery following endometrial ablation among English women with menorrhagia: population-based cohort study. BJOG (2014) 1.05
Gain-swept superradiance applied to the stand-off detection of trace impurities in the atmosphere. Proc Natl Acad Sci U S A (2005) 1.04
Loss of 9p leads to p16INK4A down-regulation and enables RB/E2F1-dependent cell cycle promotion in gastrointestinal stromal tumours (GISTs). J Pathol (2008) 1.03
A longitudinal study of the relationship of plasma somatomedin-C concentration to the pubertal growth spurt. Am J Dis Child (1987) 1.03
Suppressor of cytokine signaling (SOCS)-3 protein interacts with the insulin-like growth factor-I receptor. Biochem Biophys Res Commun (2000) 1.03
Trends in HCV prevalence among injecting drug users in Glasgow and Edinburgh during the era of needle/syringe exchange. Scand J Infect Dis (2001) 1.03
Cryptosporidial diarrhoea in South Australia. An exploratory case-control study of risk factors for transmission. Med J Aust (1993) 1.02
The ultrastructural pathology of congenital murine toxoplasmic retinochoroiditis. Part II: The morphology of the inflammatory changes. Exp Eye Res (1986) 1.02
Risk of transmission associated with sharing drug injecting paraphernalia: analysis of recent hepatitis C virus (HCV) infection using cross-sectional survey data. J Viral Hepat (2013) 1.02
Decreased expression of peroxisome proliferator-activated receptor gamma in endotoxin-induced acute lung injury. Physiol Res (2005) 1.02
Does using potting mix make you sick? Results from a Legionella longbeachae case-control study in South Australia. Epidemiol Infect (2006) 1.02
Cytokine responses in patients with mild or severe influenza A(H1N1)pdm09. J Clin Virol (2013) 1.01
Transrepression of c-jun gene expression by the glucocorticoid receptor requires both AP-1 sites in the c-jun promoter. Mol Endocrinol (1998) 1.01
High affinity antibody from hen's eggs directed against the human insulin receptor and the human IGF-I receptor. Anal Biochem (1988) 1.00
Inhibitory mechanisms of attention in identification and localization tasks: time course and disruption. J Exp Psychol Learn Mem Cogn (1991) 1.00
Hepatitis B outbreak at Glenochil prison during January to June 1993. Epidemiol Infect (1998) 1.00
Prevalence of, and risk factors for, hepatitis C virus infection among recent initiates to injecting in London and Glasgow: cross sectional analysis. J Viral Hepat (2005) 0.99
Insulin receptor signaling is augmented by antisense inhibition of the protein tyrosine phosphatase LAR. J Biol Chem (1995) 0.98
Maternal antibody to hepatitis B core antigen detected in dried neonatal blood spot samples. Epidemiol Infect (1998) 0.98
Evidence for the direct interaction of the insulin-like growth factor I receptor with IRS-1, Shc, and Grb10. Mol Endocrinol (1996) 0.97
Hepatitis C antibody detection in dried blood spots. J Viral Hepat (1999) 0.97
Prevalence of HIV-1 infection among heterosexual men and women attending genitourinary clinics in Scotland: unlinked anonymous testing. BMJ (1997) 0.97
Risk of HIV transmission from patients to surgeons in the era of post-exposure prophylaxis. J Hosp Infect (2000) 0.97
Ovine placental lactogen induces somatomedin: a a possible role in fetal growth. Endocrinology (1977) 0.96
Clinicopathologic risk factors for distant metastases from head and neck squamous cell carcinomas. Eur J Surg Oncol (2009) 0.95
Pitfalls in the somatomedin-C radioimmunoassay. J Clin Endocrinol Metab (1982) 0.95
Iron overload and liver dysfunction after allogeneic or autologous bone marrow transplantation. Bone Marrow Transplant (1996) 0.95
Somatotropin pulse frequency and basal concentrations are increased in acromegaly and are reduced by successful therapy. J Clin Endocrinol Metab (1990) 0.94
An efficacious recombinant subunit vaccine against the salmonid rickettsial pathogen Piscirickettsia salmonis. Vaccine (2001) 0.94
Consumer attitudes and behaviours--key risk factors in an outbreak of Salmonella typhimurium phage type 12 infection sourced to chicken nuggets. Aust N Z J Public Health (1999) 0.93
Selective attention in young children: the relations between visual search, filtering, and priming. J Exp Child Psychol (1987) 0.93
Transcriptional feedback and definition of the circadian pacemaker in Drosophila and animals. Cold Spring Harb Symp Quant Biol (2007) 0.93
Haplotype variation in a mitochondrial tandem repeat of Norway spruce (Picea abies) populations suggests a serious founder effect during postglacial re-colonization of the western Alps. Mol Ecol (2001) 0.92
Prevalence of hepatitis C among injectors in Scotland 1989-2000: declining trends among young injectors halt in the late 1990s. Epidemiol Infect (2002) 0.91
A protocol for the detection of Chlamydia. Nurs Stand (1993) 0.91
Chemical contrast in X-ray microscopy and spatially resolved XANES spectroscopy of organic specimens. Science (1992) 0.91
The ultrastructural pathology of congenital murine toxoplasmic retinochoroiditis. Part I: The localization and morphology of Toxoplasma cysts in the retina. Exp Eye Res (1986) 0.90
Lactose intolerance in patients with chronic functional diarrhoea: the role of small intestinal bacterial overgrowth. Aliment Pharmacol Ther (2010) 0.90
HIV infection among homosexual/bisexual males attending genitourinary clinics in Scotland. Sex Transm Infect (1998) 0.89
Relationships between stress, coping resources, and satisfaction with family functioning in families of children with disabilities. Can J Nurs Res (1994) 0.87
How can we improve organ donation rates? Research into the identification of factors which may influence the variation. Nefrologia (2001) 0.87
Growth hormone release in response to human pancreatic tumor growth hormone-releasing hormone-40 in children with short stature. J Clin Endocrinol Metab (1984) 0.87
Seronegative blood products prevent primary cytomegalovirus infection after bone marrow transplantation. J Clin Pathol (1988) 0.86
High risk injecting behaviour among injectors from Glasgow: cross sectional community wide surveys 1990-1999. J Epidemiol Community Health (2001) 0.86
Purification and characterization of C1, the catalytic subunit of Saccharomyces cerevisiae cAMP-dependent protein kinase encoded by TPK1. J Biol Chem (1988) 0.86
Population-based comparative study of campylobacter and salmonella enteritis in South Australia. Med J Aust (1982) 0.85
Overexpression of elongation factor-1gamma protein in colorectal carcinoma. Cancer (1998) 0.85